REBLOZYL® (luspatercept-aamt) logo

INDICATIONS (1 of 2)

REBLOZYL® (luspatercept-aamt) is a prescription medicine used to treat anemia (low red blood cells) in adults with myelodysplastic syndromes with ring sideroblasts (MDS-RS) or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need regular RBC transfusions and have not responded well to or cannot receive an erythropoiesis stimulating agent (ESA).

REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia.

It is not known if REBLOZYL is safe or effective in children under 18 years of age.

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

Hypothetical patient with anemia in myelodysplastic syndromes with ring sideroblasts (MDS-RS) Hypothetical patient with anemia in myelodysplastic syndromes with ring sideroblasts (MDS-RS)

Your road to
fewer transfusions

For people living with
myelodysplastic syndromes with
ring sideroblasts (MDS-RS), take
a step toward independence
from transfusions

REBLOZYL (REB-low-zil) is used to treat anemia in adults with MDS-RS

Living with MDS may cause a range of emotions. Managing anemia on top of it may make your treatment more complicated. REBLOZYL may help reduce the number of transfusions you need to treat your anemia.

You may have questions about your anemia or how REBLOZYL can help, like:

How does anemia
in MDS happen?

Learn more

What is
REBLOZYL?

Learn more

Why choose
REBLOZYL?

Learn more

Where can I find
resources and assistance?

Learn more

Frequently asked
questions

Explore
Hypothetical patient with anemia in myelodysplastic syndromes with ring sideroblasts (MDS-RS)

Frequently asked
questions

Explore
Hypothetical patient with anemia in myelodysplastic syndromes with ring sideroblasts (MDS-RS)